Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

A Hybrid FMEA-AHP Framework for Risk Prioritization in Nontransparent Artificial Intelligence Systems.

Created on 01 Jul 2026

Authors

Heitor Oliveira Gonçalves, Renato Amaral, José Cristiano Pereira

Published in

Risk analysis : an official publication of the Society for Risk Analysis. Volume 46. Issue 7. Pages e70297.

Abstract

Recent regulation, the EU AI Act and ISO/IEC 42001, requires organizations deploying high-risk artificial intelligence (AI) systems to identify, assess, and document the risks those systems generate, including risks that arise from the opacity of the underlying models. Existing risk-assessment methods leave a gap between checklist-style failure mode and effects analysis (FMEA), which is too informal for the new regulatory regime, and full probabilistic risk assessment, which is impractical for opaque deep-learning systems whose component-level failure data are not available. This paper presents a hybrid framework that adapts FMEA to AI failure modes spanning data, model, infrastructure, and ethical dimensions, and uses the analytic hierarchy process (AHP) to derive domain-specific criterion weights with an explicit consistency check. A fourth criterion, organizational impact, is added to the conventional severity, occurrence, and detectability triplet to capture the systemic regulatory and reputational consequences that traditional FMEA does not represent. The framework is illustrated on three case studies in healthcare imaging, financial fraud detection, and autonomous vehicle perception, with cross-domain weights elicited under acceptable consistency. A Monte Carlo sensitivity analysis and a cross-method robustness check against TOPSIS, ELECTRE III, and PROMETHEE II indicate that the resulting prioritization is stable both under weight perturbation and under change of aggregation logic. The framework is presented as an auditable governance tool for pre-deployment risk review, not as a replacement for FMEA in domains where it already works, and validation with independent expert panels is identified as the critical next step.

PMID:
42379550
Bibliographic data and abstract were imported from PubMed on 01 Jul 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 3
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement